Groundbreaking treatment enhances the immune system’s ability to fight cancer Holy Cross Health now offers bispecific therapy, an innovative class of antibody drugs providing new hope for patients ...

In a perspective, Northwestern Engineering’s Chad Mirkin and Milan Mrksich argue that structural precision drives therapeutic ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

AstraZeneca and Daiichi Sankyo are gunning to get Enhertu a new first-line approval in HER2-positive breast cancer after a ...

A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

In the global arena of biomedicine, Guangzhou's innovative drug companies are rewriting the rules with "hard‑core technology.

Having picked up a pipeline of oncology drugs as part of a merger last year, NAYA Biosciences is reverting back to its ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

AstraZeneca details $2.5B investment in China's political center, funding R&D center, biotech pacts Another red-hot R&D area is bispecific antibodies, a therapeutic class that has become an ...

The rapid progress in bispecific antibody development is underpinned by significant advancements in antibody engineering. US, NY, UNITED STATES, April 9, 2025 /EINPresswire / -- This surge is ...

1 Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China 2 Department of Hematology/Oncology, Puyang Oilfield General Hospital Affiliated with ...